Related Experiment Video
Updated: Feb 16, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
New natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinense
Fengyan Bao1, Kaiyin Yang2, Canrong Wu2
1Wuya College of Innovation, School of Traditional Chinese Materia Medica, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Abstract:
Hexokinase 2 (HK2), a rate-limiting enzyme in the first step of glycolysis pathway, expresses at high level in cancer cells compared with normal cells. HK2 provides a new target for cancer therapy due to its pivotal role in tumor tumourigenic and metastatic process. The structure-based virtual ligand screening in a small in-house database of natural products predicted that a new steroid, (22E,24R)-6β-methoxyergosta-7,9(11),22-triene-3β,5α-diol (2) from Ganoderma sinense has high binding affinity to HK2 with significant calculated binding free energy. Based on this prediction, compound 2, together with the other 12 steroid analogues (1, 3-13) from this plant were selected for further in vitro microscale thermophoresis (MST), enzyme inhibition, and cell-based assays based on the HK2 target. And compound 2 was finally identified as an HK2 inhibitor. As the first natural HK2 inhibitor, compound 2 can be considered as a potential drug candidate targeting at HK2 for cancer therapy.
Insights
A novel steroid from Ganoderma sinense, compound 2, is the first natural inhibitor of Hexokinase 2 (HK2). This discovery offers a potential new drug candidate for targeting HK2 in cancer therapy.
Area of Science:
- Biochemistry and Molecular Biology
- Natural Product Chemistry
- Cancer Biology
Background:
- Hexokinase 2 (HK2) is a key enzyme in glycolysis, highly expressed in cancer cells.
- HK2 plays a critical role in tumor growth and metastasis, making it a promising therapeutic target.
- Natural products are a rich source of potential anti-cancer agents.
Purpose of the Study:
- To identify novel natural product inhibitors of Hexokinase 2 (HK2).
- To evaluate the anti-cancer potential of a steroid isolated from Ganoderma sinense.
- To explore compound 2 as a potential therapeutic agent targeting HK2 in cancer.
Main Methods:
- Structure-based virtual ligand screening of natural products against HK2.
- In vitro microscale thermophoresis (MST) and enzyme inhibition assays.
- Cell-based assays to assess the biological activity of compound 2.
Main Results:
- Virtual screening predicted high binding affinity of steroid compound 2 to HK2.
- Compound 2, isolated from Ganoderma sinense, demonstrated significant HK2 inhibitory activity.
- Compound 2 was identified as the first natural inhibitor of Hexokinase 2.
Conclusions:
- Compound 2 is a potent natural inhibitor of Hexokinase 2.
- This steroid represents a potential novel drug candidate for HK2-targeted cancer therapy.
- Further investigation into compound 2's therapeutic efficacy is warranted.
More Related Videos
11:07Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
09:39Production and Testing of Moisture Behavior and Thermal Properties of Rapeseed Straw and Ganoderma resinaceum Mycelium Bio-Composites
Published on: September 5, 2025
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
What is Natural Selection?
Nature and Nurture
Chirality in Nature
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
The Wave Nature of Light